{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T21:28:52Z","timestamp":1773350932485,"version":"3.50.1"},"reference-count":40,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,1,9]],"date-time":"2008-01-09T00:00:00Z","timestamp":1199836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pain Practice"],"published-print":{"date-parts":[[2008,3]]},"abstract":"<jats:p><jats:bold>\u25aa\u2002Abstract:\u2003<\/jats:bold> The nonselective \u03b1\u2010adrenergic antagonist, phenoxybenzamine, has been used in the treatment of neuropathic pain syndromes, specifically, complex regional pain syndrome (CRPS) types I and II. This agent has also previously been used in intravenous regional peripheral blocks for treatment of CRPS I; however, an intravenous preparation of phenoxybenzamine is not currently available in the U.S.A. In this case series, systemic administration was more appropriate for three of the four patients, as their syndromes had spread beyond the initial area of surgery or trauma. We report an apparent clinical benefit in three of the four patients following oral administration. We postulate that this may be due to the noncompetitive (irreversible) blockade of \u03b1<jats:sub>1<\/jats:sub>\u2010 and \u03b1<jats:sub>2<\/jats:sub>\u2010adrenergic receptors. We further hypothesize that this blockade could reduce stimulation of an increased population of adrenergic receptors in hyperalgesic skin, blunt the stimulation by norepinephrine of \u03b1<jats:sub>2<\/jats:sub>\u2010adrenergic receptors on macrophages, and ultimately reduce the release of proinflammatory cytokines from cellular elements.\u2002\u25aa<\/jats:p>","DOI":"10.1111\/j.1533-2500.2007.00170.x","type":"journal-article","created":{"date-parts":[[2008,3,19]],"date-time":"2008-03-19T12:02:43Z","timestamp":1205928163000},"page":"125-132","source":"Crossref","is-referenced-by-count":23,"title":["Treatment of Complex Regional Pain Syndrome Type I With Oral Phenoxybenzamine: Rationale and Case Reports"],"prefix":"10.1111","volume":"8","author":[{"suffix":"Jr","given":"Mario A.","family":"Inchiosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grigory","family":"Kizelshteyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,1,9]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(95)00110-E"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.6.5.669"},{"key":"e_1_2_5_4_2","first-page":"40","volume-title":"Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms","author":"Merskey H","year":"1994"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.10.035"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.09.036"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.11.015"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1984.60.6.1263"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/sc.1996.44"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-8467(96)00594-X"},{"key":"e_1_2_5_11_2","first-page":"267","volume-title":"Goodman and Gilman's, the Pharmacological Basis of Therapeutics","author":"Westfall TC","year":"2006"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198200041-00025"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(03)00557-X"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199803000-00036"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(00)00332-8"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000166027.81432.9B"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2006.00169.x"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.7.1296"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1067\/mva.2003.78"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(95)00140-N"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.08.001"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(96)03136-3"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0910073"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/124.3.587"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08589-6"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(91)90028-V"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(00)00445-0"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.shk.0000167112.18871.5c"},{"key":"e_1_2_5_29_2","first-page":"217","article-title":"Pharmacological activities of chlorpromazine involved in the inhibition of tumour necrosis factor production in vivo in mice","volume":"79","author":"Bertini R","year":"1993","journal-title":"Immunology."},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00199431"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.145.5.1430"},{"key":"e_1_2_5_32_2","first-page":"595","article-title":"The sympathetic nerve\u2014an integrative interface between two supersystems: the brain and the immune system","volume":"52","author":"Elenkov IJ","year":"2000","journal-title":"Pharmacol Rev."},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1996.01430130046008"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(84)90246-7"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00322a021"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.173.3.699"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.20.2502"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.12.1487"},{"key":"e_1_2_5_39_2","unstructured":"Physicians' Desk Reference 61 ed. Montvale NJ:Thomson PDR;2007."},{"key":"e_1_2_5_40_2","unstructured":"USPDI Vol.1Drug Information for the Health Care Professional Vol. 2 Advice for the Patient.27th ed. Greenwood Village Coloradoa:Thomson MICROMEDEX;2007."},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(02)80003-0"}],"container-title":["Pain Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1533-2500.2007.00170.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1533-2500.2007.00170.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T12:07:11Z","timestamp":1697112431000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1533-2500.2007.00170.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,9]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["10.1111\/j.1533-2500.2007.00170.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1533-2500.2007.00170.x","archive":["Portico"],"relation":{},"ISSN":["1530-7085","1533-2500"],"issn-type":[{"value":"1530-7085","type":"print"},{"value":"1533-2500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,9]]}}}